{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:25:32Z","timestamp":1790799932561,"version":"4.1.0"},"reference-count":170,"publisher":"International Society of Endovascular Specialists","issue":"SupplementII","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Endovascular Therapy"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1583\/08-2657.1","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T12:45:46Z","timestamp":1243860346000},"page":"II31-II62","source":"Crossref","is-referenced-by-count":41,"title":["Medical and Endovascular Management of Critical Limb Ischemia"],"prefix":"10.1583","volume":"16","author":[{"given":"Alan B.","family":"Lumsden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric K.","family":"Peden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"527","reference":[{"key":"i1545-1550-16-SupplementII-31-b1","unstructured":"J. A. Dormandy, and R. B. Rutherford .Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)., J Vasc Surg, 2000 .31 :(1 Pt 2).S1 \u2013S296 ."},{"key":"i1545-1550-16-SupplementII-31-b2","doi-asserted-by":"crossref","unstructured":"L. Norgren, W. R. Hiatt, and J. A. Dormandy .et al.Inter-society consensus for the management of peripheral arterial disease (TASC II)., J Vasc Surg, 2007 .45 :(1 Suppl).S5 \u2013S67 .","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"i1545-1550-16-SupplementII-31-b3","unstructured":"Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery\/North American Chapter, International Society for Cardiovascular Surgery., J Vasc Surg, 1986 .4 :80 \u201394 ."},{"key":"i1545-1550-16-SupplementII-31-b4","doi-asserted-by":"crossref","unstructured":"R. B. Rutherford, J. D. Baker, and C. Ernst .et al.Recommended standards for reports dealing with lower extremity ischemia: revised version., J Vasc Surg, 1997 .26 :517 \u2013538 .","DOI":"10.1016\/S0741-5214(97)70045-4"},{"key":"i1545-1550-16-SupplementII-31-b5","unstructured":"R. Fontaine, M. Kim, and R. Kieny .Die chirurgische behandlung der peripheren durchblutungsstorungen [in German]., Helv Chir Acta, 1954 .5\/6 :199 \u2013533 ."},{"key":"i1545-1550-16-SupplementII-31-b6","unstructured":"Second European Consensus Document on chronic critical leg ischemia., Eur J Vasc Surg, 1992 .6 :(Suppl A).1 \u201332 ."},{"key":"i1545-1550-16-SupplementII-31-b7","doi-asserted-by":"crossref","unstructured":"M. K. Nasr, R. J. McCarthy, and J. Hardman .et al.The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischaemia., Eur J Vasc Endovasc Surg, 2002 .23 :398 \u2013403 .","DOI":"10.1053\/ejvs.2002.1615"},{"key":"i1545-1550-16-SupplementII-31-b8","doi-asserted-by":"crossref","unstructured":"D. Tsetis, and A. M. Belli .The role of infrapopliteal angioplasty., Br J Radiol, 2004 .77 :1007 \u20131015 .","DOI":"10.1259\/bjr\/97382129"},{"key":"i1545-1550-16-SupplementII-31-b9","doi-asserted-by":"crossref","unstructured":"S. Rastogi, and S. W. Stavropoulos .Infrapopliteal angioplasty., Tech Vasc Interv Radiol, 2004 .7 :33 \u201339 .","DOI":"10.1053\/j.tvir.2004.01.001"},{"key":"i1545-1550-16-SupplementII-31-b10","doi-asserted-by":"crossref","unstructured":"E. Faglia, L. Dalla Paola, and G. Clerici .et al.Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003., Eur J Vasc Endovasc Surg, 2005 .29 :620 \u2013627 .","DOI":"10.1016\/j.ejvs.2005.02.035"},{"key":"i1545-1550-16-SupplementII-31-b11","doi-asserted-by":"crossref","unstructured":"T. Kudo, F. A. Chandra, and W. H. Kwun .et al.Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery., J Vasc Surg, 2006 .44 :304 \u2013313 .","DOI":"10.1016\/j.jvs.2006.03.040"},{"key":"i1545-1550-16-SupplementII-31-b12","doi-asserted-by":"crossref","unstructured":"R. Nowygrod, N. Egorova, and G. Greco .et al.Trends, complications, and mortality in peripheral vascular surgery., J Vasc Surg, 2006 .43 :205 \u2013216 .","DOI":"10.1016\/j.jvs.2005.11.002"},{"key":"i1545-1550-16-SupplementII-31-b13","doi-asserted-by":"crossref","unstructured":"M. Bosiers, J. P. Hart, and K. Deloose .et al.Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures., Vascular, 2006 .14 :63 \u201369 .","DOI":"10.2310\/6670.2006.00014"},{"key":"i1545-1550-16-SupplementII-31-b14","doi-asserted-by":"crossref","unstructured":"M. Kalra, P. Gloviczki, and T. C. Bower .et al.Limb salvage after successful pedal bypass grafting is associated with improved long-term survival., J Vasc Surg, 2001 .33 :6 \u201316 .","DOI":"10.1067\/mva.2001.112300"},{"key":"i1545-1550-16-SupplementII-31-b15","doi-asserted-by":"crossref","unstructured":"M. A. Curi, C. L. Skelly, and Z. K. Baldwin .et al.Long-term outcome of infrainguinal bypass grafting in patients with serologically proven hypercoagulability., J Vasc Surg, 2003 .37 :301 \u2013306 .","DOI":"10.1067\/mva.2003.114"},{"key":"i1545-1550-16-SupplementII-31-b16","doi-asserted-by":"crossref","unstructured":"B. Toursarkissian, D. Stefanidis, and R. T. Hagino .et al.Early duplex-derived hemodynamic parameters after lower extremity bypass in diabetics: implications for mid-term outcomes., Ann Vasc Surg, 2002 .16 :601 \u2013607 .","DOI":"10.1007\/s10016-001-0272-8"},{"key":"i1545-1550-16-SupplementII-31-b17","doi-asserted-by":"crossref","unstructured":"F. B. Pomposelli, N. Kansal, and A. D. Hamdan .et al.A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases., J Vasc Surg, 2003 .37 :307 \u2013315 .","DOI":"10.1067\/mva.2003.125"},{"key":"i1545-1550-16-SupplementII-31-b18","doi-asserted-by":"crossref","unstructured":"K. R. Goshima, J. L. Mills, and J. D. Hughes .A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage., J Vasc Surg, 2004 .39 :330 \u2013335 .","DOI":"10.1016\/j.jvs.2003.10.020"},{"key":"i1545-1550-16-SupplementII-31-b19","doi-asserted-by":"crossref","unstructured":"A. D. Nicoloff, L. M. Taylor, and R. B. McLafferty .et al.Patient recovery after infrainguinal bypass grafting for limb salvage., J Vasc Surg, 1998 .27 :256 \u2013265 .","DOI":"10.1016\/S0741-5214(98)70356-8"},{"key":"i1545-1550-16-SupplementII-31-b20","doi-asserted-by":"crossref","unstructured":"N. Singh, A. N. Sidawy, and K. J. Dezee .et al.Factors associated with early failure of infrainguinal lower extremity arterial bypass., J Vasc Surg, 2008 .47 :556 \u2013561 .","DOI":"10.1016\/j.jvs.2007.10.059"},{"key":"i1545-1550-16-SupplementII-31-b21","doi-asserted-by":"crossref","unstructured":"M. S. Conte, D. F. Bandyk, and A. W. Clowes .et al.Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery., J Vasc Surg, 2006 .43 :742 \u2013751 .","DOI":"10.1016\/j.jvs.2005.12.058"},{"key":"i1545-1550-16-SupplementII-31-b22","doi-asserted-by":"crossref","unstructured":"M. G. Hunink, J. B. Wong, and M. C. Donaldson .et al.Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis., JAMA, 1995 .274 :165 \u2013171 .","DOI":"10.1001\/jama.274.2.165"},{"key":"i1545-1550-16-SupplementII-31-b23","doi-asserted-by":"crossref","unstructured":"L. A. Karch, M. A. Mattos, and J. P. Henretta .et al.Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries., J Vasc Surg, 2000 .31 :880 \u2013887 .","DOI":"10.1067\/mva.2000.106424"},{"key":"i1545-1550-16-SupplementII-31-b24","doi-asserted-by":"crossref","unstructured":"S. P. Lyden, and H. B. Smouse .TASC II and the endovascular management of infrainguinal disease., J Endovasc Ther, 2009 .16 :(Suppl II).II5 \u2013II18 .","DOI":"10.1583\/08-2659.1"},{"key":"i1545-1550-16-SupplementII-31-b25","doi-asserted-by":"crossref","unstructured":"E. J. Ryer, S. M. Trocciola, and B. Derubertis .et al.Analysis of outcomes following failed endovascular treatment of chronic limb ischemia., Ann Vasc Surg, 2006 .20 :440 \u2013446 .","DOI":"10.1007\/s10016-006-9101-4"},{"key":"i1545-1550-16-SupplementII-31-b26","doi-asserted-by":"crossref","unstructured":"The Vascular Surgical Society of Great Britain and Ireland, Critical limb ischemia: management and outcome. Report of a national survey., Eur J Vasc Endovasc Surg, 1995 .10 :108 \u2013113 .","DOI":"10.1016\/S1078-5884(05)80206-0"},{"key":"i1545-1550-16-SupplementII-31-b27","doi-asserted-by":"crossref","unstructured":"E. M. Willigendael, J. A. Teijink, and M. L. Bartelink .et al.Smoking and the patency of lower extremity bypass grafts: a meta-analysis., J Vasc Surg, 2005 .42 :67 \u201374 .","DOI":"10.1016\/j.jvs.2005.03.024"},{"key":"i1545-1550-16-SupplementII-31-b28","doi-asserted-by":"crossref","unstructured":"E. Adeghate, P. Schattner, and E. Dunn .An update on the etiology and epidemiology of diabetes mellitus., Ann N Y Acad Sci, 2006 .1084 :1 \u201329 .","DOI":"10.1196\/annals.1372.029"},{"key":"i1545-1550-16-SupplementII-31-b29","doi-asserted-by":"crossref","unstructured":"N. Diehm, A. Shang, and A. Silvestro .et al.Association of cardiovascular risk factors with pattern of lower limb atherosclerosis in 2659 patients undergoing angioplasty., Eur J Vasc Endovasc Surg, 2006 .31 :59 \u201363 .","DOI":"10.1016\/j.ejvs.2005.09.006"},{"key":"i1545-1550-16-SupplementII-31-b30","doi-asserted-by":"crossref","unstructured":"F. Dick, N. Diehm, and A. Galimanis .et al.Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome., J Vasc Surg, 2007 .45 :751 \u2013761 .","DOI":"10.1016\/j.jvs.2006.12.022"},{"key":"i1545-1550-16-SupplementII-31-b31","doi-asserted-by":"crossref","unstructured":"L. Graziani, A. Silvestro, and V. Bertone .et al.Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity., Eur J Vasc Endovasc Surg, 2007 .33 :453 \u2013460 .","DOI":"10.1016\/j.ejvs.2006.11.022"},{"key":"i1545-1550-16-SupplementII-31-b32","unstructured":"J. Dormandy, L. Heeck, and S. Vig .The natural history of claudication: risk to life and limb., Semin Vasc Surg, 1999 .33 :251 \u2013257 ."},{"key":"i1545-1550-16-SupplementII-31-b33","doi-asserted-by":"crossref","unstructured":"S. C. Muluk, V. S. Muluk, and M. E. Kelley .et al.Outcome events in patients with claudication: a 15-year study in 2777 patients., J Vasc Surg, 2001 .33 :251 \u2013258 .","DOI":"10.1067\/mva.2001.112210"},{"key":"i1545-1550-16-SupplementII-31-b34","doi-asserted-by":"crossref","unstructured":"J. Dormandy, G. Belcher, and P. Broos .et al.Prospective study of 713 below-knee amputations for ischaemia and the effect of a prostacyclin analogue on healing. Hawaii Study Group., Br J Surg, 1994 .81 :33 \u201337 .","DOI":"10.1002\/bjs.1800810110"},{"key":"i1545-1550-16-SupplementII-31-b35","doi-asserted-by":"crossref","unstructured":"J. A. Dormandy, B. Charbonnel, and D. J. Eckland .et al.Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial., Lancet, 2005 .366 :1279 \u20131289 .","DOI":"10.1016\/S0140-6736(05)67528-9"},{"key":"i1545-1550-16-SupplementII-31-b36","unstructured":"M. R. Nehler, and B. D. Peyton .Is revascularization and limb salvage always the treatment for critical limb ischemia? J Cardiovasc Surg (Torino), 2004 .45 :177 \u2013184 ."},{"key":"i1545-1550-16-SupplementII-31-b37","doi-asserted-by":"crossref","unstructured":"L. Pasqualini, G. Schillaci, and G. Vaudo .et al.Predictors of overall and cardiovascular mortality in peripheral arterial disease., Am J Cardiol, 2001 .88 :1057 \u20131060 .","DOI":"10.1016\/S0002-9149(01)01994-4"},{"key":"i1545-1550-16-SupplementII-31-b38","doi-asserted-by":"crossref","unstructured":"T. Pohjolainen, and H. Alaranta .Ten-year survival of Finnish lower limb amputees., Prosthet Orthot Int, 1998 .22 :10 \u201316 .","DOI":"10.3109\/03093649809164452"},{"key":"i1545-1550-16-SupplementII-31-b39","doi-asserted-by":"crossref","unstructured":"C. P. Cruz, J. F. Eidt, and C. Capps .et al.Major lower extremity amputations at a Veterans Affairs hospital., Am J Surg, 2003 .186 :449 \u2013454 .","DOI":"10.1016\/j.amjsurg.2003.07.027"},{"key":"i1545-1550-16-SupplementII-31-b40","doi-asserted-by":"crossref","unstructured":"J. Feinglass, W. H. Pearce, and G. J. Martin .et al.Postoperative and late survival outcomes after major amputation: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program., Surgery, 2001 .130 :21 \u201329 .","DOI":"10.1067\/msy.2001.115359"},{"key":"i1545-1550-16-SupplementII-31-b41","doi-asserted-by":"crossref","unstructured":"B. Subramaniam, F. Pomposelli, and D. Talmor .et al.Perioperative and long-term morbidity and mortality after above-knee and below-knee amputations in diabetics and nondiabetics., Anesth Analg, 2005 .100 :1241 \u20131247 .","DOI":"10.1213\/01.ANE.0000147705.94738.31"},{"key":"i1545-1550-16-SupplementII-31-b42","doi-asserted-by":"crossref","unstructured":"M. R. Nehler, M. M. McDermott, and D. Treat-Jacobson .et al.Functional outcomes and quality of life in peripheral arterial disease: current status., Vasc Med, 2003 .8 :115 \u2013126 .","DOI":"10.1191\/1358863x03vm483ra"},{"key":"i1545-1550-16-SupplementII-31-b43","doi-asserted-by":"crossref","unstructured":"G. J. Landry, Functional outcome of critical limb ischemia., J Vasc Surg, 2007 .45 :(Suppl A).A141 \u2013148 .","DOI":"10.1016\/j.jvs.2007.02.052"},{"key":"i1545-1550-16-SupplementII-31-b44","doi-asserted-by":"crossref","unstructured":"L. L. Nguyen, G. L. Moneta, and M. S. Conte .et al.Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia., J Vasc Surg, 2006 .44 :977 \u2013984 .","DOI":"10.1016\/j.jvs.2006.07.015"},{"key":"i1545-1550-16-SupplementII-31-b45","doi-asserted-by":"crossref","unstructured":"D. J. Adam, J. D. Beard, and T. Cleveland .et al.Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial., Lancet, 2005 .366 :1925 \u20131934 .","DOI":"10.1016\/S0140-6736(05)67704-5"},{"key":"i1545-1550-16-SupplementII-31-b46","doi-asserted-by":"crossref","unstructured":"S. C. Rose, Noninvasive vascular laboratory for evaluation of peripheral arterial occlusive disease: Part II\u2013clinical applications: chronic, usually atherosclerotic, lower extremity ischemia., J Vasc Interv Radiol, 2000 .11 :1257 \u20131275 .","DOI":"10.1016\/S1051-0443(07)61300-1"},{"key":"i1545-1550-16-SupplementII-31-b47","doi-asserted-by":"crossref","unstructured":"J. P. Eiberg, G. Madycki, and M. A. Hansen .et al.Ultrasound imaging of infrainguinal arterial disease has a high interobserver agreement., Eur J Vasc Endovasc Surg, 2002 .24 :293 \u2013299 .","DOI":"10.1053\/ejvs.2002.1724"},{"key":"i1545-1550-16-SupplementII-31-b48","doi-asserted-by":"crossref","unstructured":"O. Schlager, M. Francesconi, and M. Haumer .et al.Duplex sonography versus angiography for assessment of femoropopliteal arterial disease in a \u201creal-world\u201d setting., J Endovasc Ther, 2007 .14 :452 \u2013459 .","DOI":"10.1177\/152660280701400404"},{"key":"i1545-1550-16-SupplementII-31-b49","doi-asserted-by":"crossref","unstructured":"E. Ascher, A. P. Hingorani, and N. Marks .Duplex-guided balloon angioplasty of lower extremity arteries., Perspect Vasc Surg Endovasc Ther, 2007 .19 :23 \u201331 .","DOI":"10.1177\/1531003506298139"},{"key":"i1545-1550-16-SupplementII-31-b50","doi-asserted-by":"crossref","unstructured":"E. Ascher, N. A. Marks, and A. P. Hingorani .et al.Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases., J Vasc Surg, 2006 .44 :1230 \u20131238 .","DOI":"10.1016\/j.jvs.2006.08.025"},{"key":"i1545-1550-16-SupplementII-31-b51","doi-asserted-by":"crossref","unstructured":"M. J. Koelemay, J. G. Lijmer, and J. Stoker .et al.Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis., JAMA, 2001 .285 :1338 \u20131345 .","DOI":"10.1001\/jama.285.10.1338"},{"key":"i1545-1550-16-SupplementII-31-b52","doi-asserted-by":"crossref","unstructured":"B. Dorweiler, A. Neufang, and K. F. Kreitner .et al.Magnetic resonance angiography unmasks reliable target vessels for pedal bypass grafting in patients with diabetes mellitus., J Vasc Surg, 2002 .35 :766 \u2013772 .","DOI":"10.1067\/mva.2002.119505"},{"key":"i1545-1550-16-SupplementII-31-b53","doi-asserted-by":"crossref","unstructured":"R. Collins, J. Burch, and G. Cranny .et al.Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review., BMJ, 2007 .334 :1257 .","DOI":"10.1136\/bmj.39217.473275.55"},{"key":"i1545-1550-16-SupplementII-31-b54","doi-asserted-by":"crossref","unstructured":"T. Leiner, A. G. Kessels, and P. J. Nelemans .et al.Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis., Radiology, 2005 .235 :699 \u2013708 .","DOI":"10.1148\/radiol.2352040089"},{"key":"i1545-1550-16-SupplementII-31-b55","doi-asserted-by":"crossref","unstructured":"B. Dorweiler, A. Neufang, and W. Schmiedt .et al.Pedal arterial bypass for limb salvage in patients with diabetes mellitus., Eur J Vasc Endovasc Surg, 2002 .24 :309 \u2013313 .","DOI":"10.1053\/ejvs.2002.1735"},{"key":"i1545-1550-16-SupplementII-31-b56","doi-asserted-by":"crossref","unstructured":"R. P. Cambria, J. A. Kaufman, and G. J. L'Italien .et al.Magnetic resonance angiography in the management of lower extremity arterial occlusive disease: a prospective study., J Vasc Surg, 1997 .25 :380 \u2013389 .","DOI":"10.1016\/S0741-5214(97)70360-4"},{"key":"i1545-1550-16-SupplementII-31-b57","doi-asserted-by":"crossref","unstructured":"K. M. Ruhl, M. Katoh, and S. Langer .et al.Time-resolved 3D MR angiography of the foot at 3 T in patients with peripheral arterial disease., AJR Am J Roentgenol, 2008 .190 :W360 \u2013364 .","DOI":"10.2214\/AJR.07.2545"},{"key":"i1545-1550-16-SupplementII-31-b59","doi-asserted-by":"crossref","unstructured":"T. F. Jakobs, B. J. Wintersperger, and C. R. Becker .MDCT-imaging of peripheral arterial disease., Semin Ultrasound CT MR, 2004 .25 :145 \u2013155 .","DOI":"10.1016\/j.sult.2004.02.003"},{"key":"i1545-1550-16-SupplementII-31-b60","doi-asserted-by":"crossref","unstructured":"H. Ota, K. Takase, and K. Igarashi .et al.MDCT compared with digital subtraction angiography for assessment of lower extremity arterial occlusive disease: importance of reviewing cross-sectional images., AJR Am J Roentgenol, 2004 .182 :201 \u2013209 .","DOI":"10.2214\/ajr.182.1.1820201"},{"key":"i1545-1550-16-SupplementII-31-b61","doi-asserted-by":"crossref","unstructured":"M. S. Conte, D. F. Bandyk, and A. W. Clowes .et al.Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial., J Vasc Surg, 2005 .42 :456 \u2013465 .","DOI":"10.1016\/j.jvs.2005.05.001"},{"key":"i1545-1550-16-SupplementII-31-b62","doi-asserted-by":"crossref","unstructured":"R. G. Frykberg, An evidence-based approach to diabetic foot infections., Am J Surg, 2003 .186 :44S \u201354S; discussion 61S\u201364S .","DOI":"10.1016\/j.amjsurg.2003.10.008"},{"key":"i1545-1550-16-SupplementII-31-b63","doi-asserted-by":"crossref","unstructured":"G. P. Clagett, M. Sobel, and M. R. Jackson .et al.Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy., Chest, 2004 .126 :(3 Suppl).609S \u2013626S .","DOI":"10.1378\/chest.126.3_suppl.609S"},{"key":"i1545-1550-16-SupplementII-31-b64","doi-asserted-by":"crossref","unstructured":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death myocardial infarction, and stroke in high risk patients., BMJ, 2002 .324 :71 \u201386 .","DOI":"10.1136\/bmj.324.7329.71"},{"key":"i1545-1550-16-SupplementII-31-b65","doi-asserted-by":"crossref","unstructured":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), CAPRIE Steering Committee., Lancet, 1996 .348 :1329 \u20131339 .","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"i1545-1550-16-SupplementII-31-b66","doi-asserted-by":"crossref","unstructured":"D. L. Bhatt, K. A. Fox, and W. Hacke .et al.Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events., N Engl J Med, 2006 .354 :1706 \u20131717 .","DOI":"10.1056\/NEJMoa060989"},{"key":"i1545-1550-16-SupplementII-31-b67","unstructured":"D. L. Bhatt, M. D. Flather, and W. Hacke .et al.Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial., J Am Coll Cardiol, 2007 .49 :1982 \u20131988 ."},{"key":"i1545-1550-16-SupplementII-31-b68","doi-asserted-by":"crossref","unstructured":"S. Anand, S. Yusuf, and C. Xie .et al.Oral anticoagulant and antiplatelet therapy and peripheral arterial disease., N Engl J Med, 2007 .357 :217 \u2013227 .","DOI":"10.1056\/NEJMoa065959"},{"key":"i1545-1550-16-SupplementII-31-b69","doi-asserted-by":"crossref","unstructured":"M. Schillinger, N. Diehm, and I. Baumgartner .et al.TASC II section F on revascularization: commentary from an interventionist's point of view., J Endovasc Ther, 2007 .14 :734 \u2013742 .","DOI":"10.1177\/152660280701400519"},{"key":"i1545-1550-16-SupplementII-31-b70","doi-asserted-by":"crossref","unstructured":"M. W. Mewissen, Primary nitinol stenting for femoropopliteal disease., J Endovasc Ther, 2009 .16 :(Suppl II).II63 \u2013II81 .","DOI":"10.1583\/08-2658.1"},{"key":"i1545-1550-16-SupplementII-31-b71","doi-asserted-by":"crossref","unstructured":"G. M. Ansel, M. J. Silver, and C. F. Botti .et al.Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: a randomized trial., Catheter Cardiovasc Interv, 2006 .67 :288 \u2013297 .","DOI":"10.1002\/ccd.20593"},{"key":"i1545-1550-16-SupplementII-31-b72","doi-asserted-by":"crossref","unstructured":"O. Iida, S. Nanto, and M. Uematsu .et al.Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions., J Vasc Surg, 2008 .48 :144 \u2013149 .","DOI":"10.1016\/j.jvs.2008.02.062"},{"key":"i1545-1550-16-SupplementII-31-b73","doi-asserted-by":"crossref","unstructured":"B. G. Brown, X. Q. Zhao, and A. Chait .et al.Simvastatin and niacin, antioxidant vitamins, or the combination in the prevention of coronary disease., N Engl J Med, 2001 .345 :1583 \u20131592 .","DOI":"10.1056\/NEJMoa011090"},{"key":"i1545-1550-16-SupplementII-31-b74","doi-asserted-by":"crossref","unstructured":"M. H. Davidson, T. McGarry, and R. Bettis .et al.Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia., J Am Coll Cardiol, 2002 .40 :2125 \u20132134 .","DOI":"10.1016\/S0735-1097(02)02610-4"},{"key":"i1545-1550-16-SupplementII-31-b75","doi-asserted-by":"crossref","unstructured":"C. M. Ballantyne, J. Houri, and A. Notarbartolo .et al.Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized double-blind trial., Circulation, 2003 .107 :2409 \u20132415 .","DOI":"10.1161\/01.CIR.0000068312.21969.C8"},{"key":"i1545-1550-16-SupplementII-31-b76","unstructured":"G. C. Leng, J. F. Price, and R. G. Jepson .Lipid-lowering for lower limb atherosclerosis., Cochrane Database Syst Rev, 2000 .2 :CD000123 ."},{"key":"i1545-1550-16-SupplementII-31-b77","doi-asserted-by":"crossref","unstructured":"S. Mondillo, P. Ballo, and R. Barbati .et al.Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease., Am J Med, 2003 .114 :359 \u2013364 .","DOI":"10.1016\/S0002-9343(03)00010-X"},{"key":"i1545-1550-16-SupplementII-31-b78","doi-asserted-by":"crossref","unstructured":"D. Poldermans, J. Bax, and M. Kertai .et al.Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery., Circulation, 2003 .107 :1848 \u20131851 .","DOI":"10.1161\/01.CIR.0000066286.15621.98"},{"key":"i1545-1550-16-SupplementII-31-b79","doi-asserted-by":"crossref","unstructured":"D. Poldermans, E. Boersma, and J. J. Bax .et al.Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery., Eur Heart J, 2001 .22 :1353 \u20131358 .","DOI":"10.1053\/euhj.2000.2555"},{"key":"i1545-1550-16-SupplementII-31-b80","doi-asserted-by":"crossref","unstructured":"E. Boersma, D. Poldermans, and J. J. Bax .et al.Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy., JAMA, 2001 .285 :1865 \u20131873 .","DOI":"10.1001\/jama.285.14.1865"},{"key":"i1545-1550-16-SupplementII-31-b81","doi-asserted-by":"crossref","unstructured":"D. Mangano, E. Layug, and A. Wallace .et al.Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group., N Engl J Med, 1996 .335 :1713 \u20131720 .","DOI":"10.1056\/NEJM199612053352301"},{"key":"i1545-1550-16-SupplementII-31-b82","doi-asserted-by":"crossref","unstructured":"D. L. Dawson, B. S. Cutler, and W. R. Hiatt .et al.A comparison of cilostazol and pentoxifylline for treating intermittent claudication., Am J Med, 2000 .109 :523 \u2013530 .","DOI":"10.1016\/S0002-9343(00)00569-6"},{"key":"i1545-1550-16-SupplementII-31-b83","doi-asserted-by":"crossref","unstructured":"Y. Liu, Y. Shakur, and M. Yoshitake .et al.Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake., Cardiovasc Drug Rev, 2001 .19 :369 \u2013386 .","DOI":"10.1111\/j.1527-3466.2001.tb00076.x"},{"key":"i1545-1550-16-SupplementII-31-b84","doi-asserted-by":"crossref","unstructured":"D. L. Dawson, B. S. Cutler, and M. H. Meissner .et al.Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial., Circulation, 1998 .98 :678 \u2013686 .","DOI":"10.1161\/01.CIR.98.7.678"},{"key":"i1545-1550-16-SupplementII-31-b85","doi-asserted-by":"crossref","unstructured":"H. G. Beebe, D. L. Dawson, and B. S. Cutler .et al.A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial., Arch Intern Med, 1999 .159 :2041 \u20132050 .","DOI":"10.1001\/archinte.159.17.2041"},{"key":"i1545-1550-16-SupplementII-31-b86","doi-asserted-by":"crossref","unstructured":"P. D. Thompson, R. Zimet, and W. P. Forbes .et al.Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication., Am J Cardiol, 2002 .90 :1314 \u20131319 .","DOI":"10.1016\/S0002-9149(02)02869-2"},{"key":"i1545-1550-16-SupplementII-31-b87","doi-asserted-by":"crossref","unstructured":"P. Robless, D. P. Mikhailidis, and G. P. Stansby .Cilostazol for peripheral arterial disease., Cochrane Database Syst Rev, 2008 .1 :CD003748 .","DOI":"10.1002\/14651858.CD003748.pub3"},{"key":"i1545-1550-16-SupplementII-31-b88","doi-asserted-by":"crossref","unstructured":"T. E. Rowlands, and R. Donnelly .Medical therapy for intermittent claudication., Eur J Vasc Endovasc Surg, 2007 .34 :314 \u2013321 .","DOI":"10.1016\/j.ejvs.2007.04.001"},{"key":"i1545-1550-16-SupplementII-31-b89","doi-asserted-by":"crossref","unstructured":"M. G. Davies, D. L. Waldman, and T. A. Pearson .Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease., J Am Coll Surg, 2005 .201 :275 \u2013296 .","DOI":"10.1016\/j.jamcollsurg.2005.03.007"},{"key":"i1545-1550-16-SupplementII-31-b90","doi-asserted-by":"crossref","unstructured":"M. Simons, Angiogenesis: where do we stand now? Circulation, 2005 .111 :1556 \u20131566 .","DOI":"10.1161\/01.CIR.0000159345.00591.8F"},{"key":"i1545-1550-16-SupplementII-31-b91","doi-asserted-by":"crossref","unstructured":"J. Tongers, J. G. Roncalli, and D. W. Losordo .Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age., Circulation, 2008 .118 :9 \u201316 .","DOI":"10.1161\/CIRCULATIONAHA.108.784371"},{"key":"i1545-1550-16-SupplementII-31-b92","doi-asserted-by":"crossref","unstructured":"R. J. Powell, M. Simons, and F. O. Mendelsohn .et al.Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia., Circulation, 2008 .118 :58 \u201365 .","DOI":"10.1161\/CIRCULATIONAHA.107.727347"},{"key":"i1545-1550-16-SupplementII-31-b93","doi-asserted-by":"crossref","unstructured":"S. Nikol, I. Baumgartner, and E. Van Belle .et al.Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia., Mol Ther, 2008 .16 :972 \u2013978 .","DOI":"10.1038\/mt.2008.33"},{"key":"i1545-1550-16-SupplementII-31-b94","unstructured":"J. Emmerich, and J. N. Fiessinger .Medical treatment of critical leg ischemia: current status and future perspectives of gene and cell therapy [in French]., Bull Acad Natl Med, 2006 .190 :667 \u2013684 ."},{"key":"i1545-1550-16-SupplementII-31-b95","doi-asserted-by":"crossref","unstructured":"C. W. Bakal, S. Sprayregen, and K. Scheinbaum .et al.Percutaneous transluminal angioplasty of the infrapopliteal arteries: results in 53 patients., AJR Am J Roentgenol, 1990 .154 :171 \u2013174 .","DOI":"10.2214\/ajr.154.1.2136784"},{"key":"i1545-1550-16-SupplementII-31-b96","doi-asserted-by":"crossref","unstructured":"G. Dorros, M. R. Jaff, and A. M. Dorros .et al.Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up., Circulation, 2001 .104 :2057 \u20132062 .","DOI":"10.1161\/hc4201.097943"},{"key":"i1545-1550-16-SupplementII-31-b97","doi-asserted-by":"crossref","unstructured":"H. K. Soder, H. I. Manninen, and P. Jaakkola .et al.Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results., J Vasc Interv Radiol, 2000 .11 :1021 \u20131031 .","DOI":"10.1016\/S1051-0443(07)61332-3"},{"key":"i1545-1550-16-SupplementII-31-b98","doi-asserted-by":"crossref","unstructured":"S. M. Trocciola, R. Chaer, and R. Dayal .et al.Comparison of results in endovascular interventions for infrainguinal lesions: claudication versus critical limb ischemia., Am Surg, 2005 .71 :474 \u2013480 .","DOI":"10.1177\/000313480507100605"},{"key":"i1545-1550-16-SupplementII-31-b99","doi-asserted-by":"crossref","unstructured":"T. Kudo, F. A. Chandra, and S. S. Ahn .The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience., J Vasc Surg, 2005 .41 :423 \u2013435 .","DOI":"10.1016\/j.jvs.2004.11.041"},{"key":"i1545-1550-16-SupplementII-31-b100","doi-asserted-by":"crossref","unstructured":"S. I. Myers, D. J. Myers, and A. Ahmend .et al.Preliminary results of subintimal angioplasty for limb salvage in lower extremities with severe chronic ischemia and limb-threatening ischemia., J Vasc Surg, 2006 .44 :1239 \u20131246 .","DOI":"10.1016\/j.jvs.2006.08.022"},{"key":"i1545-1550-16-SupplementII-31-b101","doi-asserted-by":"crossref","unstructured":"H. Vraux, and N. Bertoncello .Subintimal angioplasty of tibial vessel occlusions in critical limb ischaemia: a good opportunity? Eur J Vasc Endovasc Surg, 2006 .32 :663 \u2013667 .","DOI":"10.1016\/j.ejvs.2006.06.006"},{"key":"i1545-1550-16-SupplementII-31-b102","doi-asserted-by":"crossref","unstructured":"A. M. Lazaris, C. Salas, and A. C. Tsiamis .et al.Factors affecting patency of subintimal infrainguinal angioplasty in patients with critical lower limb ischemia., Eur J Vasc Endovasc Surg, 2006 .32 :668 \u2013674 .","DOI":"10.1016\/j.ejvs.2006.07.016"},{"key":"i1545-1550-16-SupplementII-31-b103","doi-asserted-by":"crossref","unstructured":"D. J. Spinosa, D. A. Leung, and A. H. Matsumoto .et al.Percutaneous intentional extraluminal recanalization in patients with chronic critical limb ischemia., Radiology, 2004 .232 :499 \u2013507 .","DOI":"10.1148\/radiol.2322030729"},{"key":"i1545-1550-16-SupplementII-31-b104","doi-asserted-by":"crossref","unstructured":"N. Hynes, Y. Akhtar, and B. Manning .et al.Subintimal angioplasty as a primary modality in the management of critical limb ischemia: comparison to bypass grafting for aortoiliac and femoropopliteal occlusive disease., J Endovasc Ther, 2004 .11 :460 \u2013471 .","DOI":"10.1583\/04-1242.1"},{"key":"i1545-1550-16-SupplementII-31-b105","doi-asserted-by":"crossref","unstructured":"J. S. Kim, T. S. Kang, and C. M. Ahn .et al.Efficacy of subintimal angioplasty\/stent implantation for long, multisegmental lower limb occlusive lesions in patients unsuitable for surgery., J Endovasc Ther, 2006 .13 :514 \u2013521 .","DOI":"10.1583\/05-1798MR.1"},{"key":"i1545-1550-16-SupplementII-31-b106","doi-asserted-by":"crossref","unstructured":"M. Akesson, L. Riva, and K. Ivancev .et al.Subintimal angioplasty of infrainguinal arterial occlusions for critical limb ischemia: long-term patency and clinical efficacy., J Endovasc Ther, 2007 .14 :444 \u2013451 .","DOI":"10.1177\/152660280701400403"},{"key":"i1545-1550-16-SupplementII-31-b107","doi-asserted-by":"crossref","unstructured":"J. P. Becquemin, J. P. Favre, and J. Marzelle .et al.Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study., J Vasc Surg, 2003 .37 :487 \u2013494 .","DOI":"10.1067\/mva.2003.155"},{"key":"i1545-1550-16-SupplementII-31-b108","unstructured":"B. Wiesinger, S. Heller, and J. Schmehl .et al.Percutaneous vascular interventions in the superficial femoral artery. A review., Minerva Cardioangiol, 2006 .54 :83 \u201393 ."},{"key":"i1545-1550-16-SupplementII-31-b109","doi-asserted-by":"crossref","unstructured":"M. W. Mewissen, Stenting in the femoropopliteal arterial segment., Tech Vasc Interv Radiol, 2005 .8 :146 \u2013149 .","DOI":"10.1053\/j.tvir.2006.05.003"},{"key":"i1545-1550-16-SupplementII-31-b110","doi-asserted-by":"crossref","unstructured":"T. R. Vogel, L. E. Shindelman, and G. B. Nackman .et al.Efficacious use of nitinol stents in the femoral and popliteal arteries., J Vasc Surg, 2003 .38 :1178 \u20131184 .","DOI":"10.1016\/j.jvs.2003.09.011"},{"key":"i1545-1550-16-SupplementII-31-b111","doi-asserted-by":"crossref","unstructured":"S. H. Duda, B. Pusich, and G. Richter .et al.Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results., Circulation, 2002 .106 :1505 \u20131509 .","DOI":"10.1161\/01.CIR.0000029746.10018.36"},{"key":"i1545-1550-16-SupplementII-31-b112","doi-asserted-by":"crossref","unstructured":"S. H. Duda, M. Bosiers, and J. Lammer .et al.Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial., J Vasc Interv Radiol, 2005 .16 :331 \u2013338 .","DOI":"10.1097\/01.RVI.0000151260.74519.CA"},{"key":"i1545-1550-16-SupplementII-31-b113","doi-asserted-by":"crossref","unstructured":"S. H. Duda, M. Bosiers, and J. Lammer .et al.Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial., J Endovasc Ther, 2006 .13 :701 \u2013710 .","DOI":"10.1583\/05-1704.1"},{"key":"i1545-1550-16-SupplementII-31-b114","doi-asserted-by":"crossref","unstructured":"M. Schillinger, S. Sabeti, and C. Loewe .et al.Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery., N Engl J Med, 2006 .354 :1879 \u20131888 .","DOI":"10.1056\/NEJMoa051303"},{"key":"i1545-1550-16-SupplementII-31-b115","doi-asserted-by":"crossref","unstructured":"M. Schillinger, S. Sabeti, and P. Dick .et al.Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting., Circulation, 2007 .115 :2745 \u20132749 .","DOI":"10.1161\/CIRCULATIONAHA.107.688341"},{"key":"i1545-1550-16-SupplementII-31-b116","unstructured":"J. Laird, Lessons learned in RESILIENT (interview)., Endovascular Today, 2008 .October :59 \u201362 ."},{"key":"i1545-1550-16-SupplementII-31-b117","doi-asserted-by":"crossref","unstructured":"M. Ferreira, L. Lanziotti, and M. Monteiro .et al.Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results., Eur J Vasc Endovasc Surg, 2007 .34 :702 \u2013708 .","DOI":"10.1016\/j.ejvs.2007.07.025"},{"key":"i1545-1550-16-SupplementII-31-b118","doi-asserted-by":"crossref","unstructured":"G. M. Ansel, and A. B. Lumsden .Evolving modalities for femoropopliteal interventions., J Endovasc Ther, 2009 .16 :(Suppl II).II82 \u2013II97 .","DOI":"10.1583\/08-2654.1"},{"key":"i1545-1550-16-SupplementII-31-b119","unstructured":"M. Dake, The Zilver PTX global registry and RCT (interview)., Endovascular Today, 2008 .October :63 \u201364 ."},{"key":"i1545-1550-16-SupplementII-31-b120","unstructured":"D. Brunk, Drug-eluting stent proves durable at 6- and 12-month follow-up., Am Coll Surg: Surg News, 2008 .4 :12 ."},{"key":"i1545-1550-16-SupplementII-31-b121","doi-asserted-by":"crossref","unstructured":"M. Fischer, C. Schwabe, and K. L. Schulte .Value of the Hemobahn\/Viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience., J Endovasc Ther, 2006 .13 :281 \u2013290 .","DOI":"10.1583\/05-1799.1"},{"key":"i1545-1550-16-SupplementII-31-b122","doi-asserted-by":"crossref","unstructured":"R. R. Saxon, J. M. Coffman, and J. M. Gooding .et al.Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions., J Vasc Interv Radiol, 2007 .18 :1341 \u20131349 .","DOI":"10.1016\/j.jvir.2007.07.011"},{"key":"i1545-1550-16-SupplementII-31-b123","doi-asserted-by":"crossref","unstructured":"Y. S. Alimi, Z. Hakam, and O. Hartung .et al.Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency? Eur J Vasc Endovasc Surg, 2008 .35 :346 \u2013352 .","DOI":"10.1016\/j.ejvs.2007.09.005"},{"key":"i1545-1550-16-SupplementII-31-b124","doi-asserted-by":"crossref","unstructured":"G. M. Ansel, C. F. Botti, and M. J. Silver .The use of femoropopliteal stent-grafts for critical limb ischemia., Tech Vasc Interv Radiol, 2005 .8 :140 \u2013145 .","DOI":"10.1053\/j.tvir.2006.04.002"},{"key":"i1545-1550-16-SupplementII-31-b125","doi-asserted-by":"crossref","unstructured":"J. Kedora, S. Hohmann, and W. Garrett .et al.Randomized comparison of percutaneous Viabahn stent grafts versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease., J Vasc Surg, 2007 .45 :10 \u201316 .","DOI":"10.1016\/j.jvs.2006.08.074"},{"key":"i1545-1550-16-SupplementII-31-b126","doi-asserted-by":"crossref","unstructured":"D. H. Burger, A. P. Kappetein, and J. H. Van Bockel .et al.A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting., J Vasc Surg, 2000 .32 :278 \u2013283 .","DOI":"10.1067\/mva.2000.106496"},{"key":"i1545-1550-16-SupplementII-31-b128","doi-asserted-by":"crossref","unstructured":"A. J. Feiring, A. A. Wesolowski, and S. Lade .Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes., J Am Coll Cardiol, 2004 .44 :2307 \u20132314 .","DOI":"10.1016\/j.jacc.2004.09.037"},{"key":"i1545-1550-16-SupplementII-31-b129","doi-asserted-by":"publisher","DOI":"10.1583\/05-1620MR.1"},{"key":"i1545-1550-16-SupplementII-31-b130","doi-asserted-by":"publisher","DOI":"10.1583\/1545-1550(2007)14[241:SVBSAS]2.0.CO;2"},{"key":"i1545-1550-16-SupplementII-31-b131","unstructured":"D. Scheinert, M. Ulrich, and S. Scheinert .et al.Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions., EuroIntervention, 2006 ."},{"key":"i1545-1550-16-SupplementII-31-b132","doi-asserted-by":"crossref","unstructured":"P. Commeau, P. Barragan, and P. O. Roquebert .Sirolimus for below the knee lesions: mid-term results of SiroBTK study., Catheter Cardiovasc Interv, 2006 .68 :793 \u2013798 .","DOI":"10.1002\/ccd.20893"},{"key":"i1545-1550-16-SupplementII-31-b133","unstructured":"M. Bosiers, K. Deloose, and J. Verbist .et al.Percutaneous transluminal angioplasty for treatment of \u201cbelow-the-knee\u201d critical limb ischemia: early outcomes following the use of sirolimus-eluting stents., J Cardiovasc Surg (Torino), 2006 .47 :171 \u2013176 ."},{"key":"i1545-1550-16-SupplementII-31-b135","doi-asserted-by":"crossref","unstructured":"T. Rand, A. Basile, and M. Cejna .et al.PTA versus carbofilm-coated stents in infrapopliteal arteries: pilot study., Cardiovasc Intervent Radiol, 2006 .29 :29 \u201338 .","DOI":"10.1007\/s00270-005-0276-9"},{"key":"i1545-1550-16-SupplementII-31-b137","doi-asserted-by":"crossref","unstructured":"A. Schwarzmaier-D'Assie, R. Karnik, and G. Bonner .et al.Fracture of a drug-eluting stent in the tibioperoneal trunk following bifurcation stenting., J Endovasc Ther, 2007 .14 :106 \u2013109 .","DOI":"10.1583\/06-1893.1"},{"key":"i1545-1550-16-SupplementII-31-b138","unstructured":"M. Bosiers, K. Deloose, and J. Verbist .et al.Nitinol stenting for treatment of \u201cbelow-the-knee\u201d critical limb ischemia: 1-year angiographic outcome after Xpert stent implantation., J Cardiovasc Surg (Torino), 2007 .48 :455 \u2013461 ."},{"key":"i1545-1550-16-SupplementII-31-b139","doi-asserted-by":"crossref","unstructured":"R. Kickuth, H. H. Keo, and J. Triller .et al.Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia., J Vasc Interv Radiol, 2007 .18 :703 \u2013708 .","DOI":"10.1016\/j.jvir.2007.03.012"},{"key":"i1545-1550-16-SupplementII-31-b140","doi-asserted-by":"crossref","unstructured":"M. Fava, S. Loyola, and A. Polydorou .et al.Cryoplasty for femoropopliteal arterial disease: late angiographic results of initial human experience., J Vasc Interv Radiol, 2004 .15 :1239 \u20131243 .","DOI":"10.1097\/01.RVI.0000136291.07304.EA"},{"key":"i1545-1550-16-SupplementII-31-b141","doi-asserted-by":"crossref","unstructured":"J. Laird, M. R. Jaff, and G. Biamino .et al.Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry., J Vasc Interv Radiol, 2005 .16 :1067 \u20131073 .","DOI":"10.1097\/01.RVI.0000167866.86201.4E"},{"key":"i1545-1550-16-SupplementII-31-b142","doi-asserted-by":"crossref","unstructured":"J. R. Laird, G. Biamino, and T. McNamara .et al.Cryoplasty for the treatment of femoropopliteal arterial disease: extended follow-up results., J Endovasc Ther, 2006 .13 :(Suppl II).52 \u201359 .","DOI":"10.1583\/05-1755.1"},{"key":"i1545-1550-16-SupplementII-31-b143","doi-asserted-by":"crossref","unstructured":"T. Das, T. McNamara, and B. Gray .et al.Cryoplasty therapy for limb salvage in patients with critical limb ischemia., J Endovasc Ther, 2007 .14 :753 \u2013762 .","DOI":"10.1583\/07-2147.1"},{"key":"i1545-1550-16-SupplementII-31-b144","doi-asserted-by":"crossref","unstructured":"T. S. Das, T. McNamara, and B. Gray .et al.Primary cryoplasty therapy provides durable support for limb salvage in CLI patients with infrapopliteal lesions: 12-month follow-up results from the BTK Chill trial., J Endovasc Ther, 2009 .16 :(Suppl II).II19 \u2013II30 .","DOI":"10.1583\/08-2652.1"},{"key":"i1545-1550-16-SupplementII-31-b145","doi-asserted-by":"crossref","unstructured":"J. R. Laird, and D. L. Dawson .The role for cryoplasty in the treatment of infrainguinal artery disease: case studies., J Endovasc Ther, 2009 .16 :(Suppl II).II116 \u2013II128 .","DOI":"10.1583\/08-2653.1"},{"key":"i1545-1550-16-SupplementII-31-b146","doi-asserted-by":"crossref","unstructured":"J. F. Rabbi, R. P. Kiran, and G. Gersten .et al.Early results with infrainguinal cutting balloon angioplasty limits distal dissection., Ann Vasc Surg, 2004 .18 :640 \u2013643 .","DOI":"10.1007\/s10016-004-0103-9"},{"key":"i1545-1550-16-SupplementII-31-b147","doi-asserted-by":"crossref","unstructured":"G. M. Ansel, N. S. Sample, and C. Botti .et al.Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia., Catheter Cardiovasc Interv, 2004 .61 :1 \u20134 .","DOI":"10.1002\/ccd.10731"},{"key":"i1545-1550-16-SupplementII-31-b148","doi-asserted-by":"crossref","unstructured":"C. Engelke, R. A. Morgan, and A. M. Belli .Cutting balloon percutaneous transluminal angioplasty for salvage of lower limb arterial bypass grafts: feasibility., Radiology, 2002 .223 :106 \u2013114 .","DOI":"10.1148\/radiol.2231010793"},{"key":"i1545-1550-16-SupplementII-31-b149","doi-asserted-by":"crossref","unstructured":"K. Kasirajan, and P. A. Schneider .Early outcome of \u201ccutting\u201d balloon angioplasty for infrainguinal vein graft stenosis., J Vasc Surg, 2004 .39 :702 \u2013708 .","DOI":"10.1016\/j.jvs.2003.10.046"},{"key":"i1545-1550-16-SupplementII-31-b150","doi-asserted-by":"crossref","unstructured":"R. Garvin, and T. Reifsnyder .Cutting balloon angioplasty of autogenous infrainguinal bypasses: short-term safety and efficacy., J Vasc Surg, 2007 .46 :724 \u2013730 .","DOI":"10.1016\/j.jvs.2007.05.056"},{"key":"i1545-1550-16-SupplementII-31-b151","doi-asserted-by":"crossref","unstructured":"T. S. Das, Excimer laser-assisted angioplasty for infrainguinal artery disease., J Endovasc Ther, 2009 .16 :(Suppl II).II98 \u2013II105 .","DOI":"10.1583\/08-2655.1"},{"key":"i1545-1550-16-SupplementII-31-b152","doi-asserted-by":"crossref","unstructured":"D. G. Clair, Critical limb ischemia: will atherectomy and laser-directed therapy be the answer? Semin Vasc Surg, 2006 .19 :96 \u2013101 .","DOI":"10.1053\/j.semvascsurg.2006.03.006"},{"key":"i1545-1550-16-SupplementII-31-b153","doi-asserted-by":"crossref","unstructured":"S. Shafique, R. D. Nachreiner, and M. P. Murphy .et al.Recanalization of infrainguinal vessels: SilverHawk, laser, and the remote superficial femoral artery endarterectomy., Semin Vasc Surg, 2007 .20 :29 \u201336 .","DOI":"10.1053\/j.semvascsurg.2007.02.002"},{"key":"i1545-1550-16-SupplementII-31-b155","doi-asserted-by":"crossref","unstructured":"A. Rastan, S. Sixt, and U. Schwarzwalder .et al.Initial experience with directed laser atherectomy using the CLiRpath photoablation atherectomy system and bias sheath in superficial femoral artery lesions., J Endovasc Ther, 2007 .14 :365 \u2013373 .","DOI":"10.1583\/06-2046.1"},{"key":"i1545-1550-16-SupplementII-31-b156","doi-asserted-by":"crossref","unstructured":"C. Wissgott, D. Scheinert, and J. Rademaker .et al.Treatment of long superficial femoral artery occlusions with excimer laser angioplasty: long-term results after 48 months., Acta Radiol, 2004 .45 :23 \u201329 .","DOI":"10.1080\/02841850410000746"},{"key":"i1545-1550-16-SupplementII-31-b157","doi-asserted-by":"crossref","unstructured":"D. Scheinert, J. R. Laird, and M. Schroder .et al.Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions., J Endovasc Ther, 2001 .8 :156 \u2013166 .","DOI":"10.1177\/152660280100800210"},{"key":"i1545-1550-16-SupplementII-31-b158","doi-asserted-by":"crossref","unstructured":"H. J. Steinkamp, M. Werk, and M. Haufe .et al.Laser angioplasty of peripheral arteries after unsuccessful recanalization of the superficial femoral artery., Int J Cardiovasc Intervent, 2000 .3 :153 \u2013160 .","DOI":"10.1080\/14628840050516064"},{"key":"i1545-1550-16-SupplementII-31-b159","unstructured":"J. R. Laird, C. Reiser, and G. Biamino .et al.Excimer laser assisted angioplasty for the treatment of critical limb ischemia., J Cardiovasc Surg (Torino), 2004 .45 :239 \u2013248 ."},{"key":"i1545-1550-16-SupplementII-31-b160","doi-asserted-by":"crossref","unstructured":"J. R. Laird, T. Zeller, and B. H. Gray .et al.Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial., J Endovasc Ther, 2006 .13 :1 \u201311 .","DOI":"10.1583\/05-1674.1"},{"key":"i1545-1550-16-SupplementII-31-b161","doi-asserted-by":"crossref","unstructured":"M. Bosiers, P. Peeters, and F. V. Elst .et al.Excimer laser assisted angioplasty for critical limb ischemia: results of the LACI Belgium Study., Eur J Vasc Endovasc Surg, 2005 .29 :613 \u2013619 .","DOI":"10.1016\/j.ejvs.2005.01.008"},{"key":"i1545-1550-16-SupplementII-31-b162","doi-asserted-by":"crossref","unstructured":"G. Biamino, The excimer laser: science fiction fantasy or practical tool? J Endovasc Ther, 2004 .11 :(Suppl II).II207 \u2013222 .","DOI":"10.1583\/04-1394.1"},{"key":"i1545-1550-16-SupplementII-31-b163","doi-asserted-by":"crossref","unstructured":"M. C. Stoner, D. J. deFreitas, and S. V. Phade .et al.Mid-term results with laser atherectomy in the treatment of infrainguinal occlusive disease., J Vasc Surg, 2007 .46 :289 \u2013295 .","DOI":"10.1016\/j.jvs.2007.04.019"},{"key":"i1545-1550-16-SupplementII-31-b164","doi-asserted-by":"crossref","unstructured":"S. S. Ahn, and B. Concepcion .Current status of atherectomy for peripheral arterial occlusive disease., World J Surg, 1996 .20 :635 \u2013643 .","DOI":"10.1007\/s002689900097"},{"key":"i1545-1550-16-SupplementII-31-b165","doi-asserted-by":"crossref","unstructured":"A. V. Tielbeek, D. Vroegindeweij, and J. Buth .et al.Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial., J Vasc Interv Radiol, 1996 .7 :837 \u2013844 .","DOI":"10.1016\/S1051-0443(96)70857-6"},{"key":"i1545-1550-16-SupplementII-31-b166","doi-asserted-by":"crossref","unstructured":"L. A. Garcia, and S. P. Lyden .Atherectomy for infrainguinal peripheral artery disease., J Endovasc Ther, 2009 .16 :(Suppl II).II105 \u2013II115 .","DOI":"10.1583\/08-2656.1"},{"key":"i1545-1550-16-SupplementII-31-b167","doi-asserted-by":"crossref","unstructured":"T. Zeller, A. Rastan, and S. Sixt .et al.Long-term results after directional atherectomy of femoro-popliteal lesions., J Am Coll Cardiol, 2006 .48 :1573 \u20131578 .","DOI":"10.1016\/j.jacc.2006.07.031"},{"key":"i1545-1550-16-SupplementII-31-b168","doi-asserted-by":"crossref","unstructured":"T. Zeller, S. Sixt, and U. Schwarzwalder .et al.Two-year results after directional atherectomy of infrapopliteal arteries with the SilverHawk device., J Endovasc Ther, 2007 .14 :232 \u2013240 .","DOI":"10.1177\/152660280701400216"},{"key":"i1545-1550-16-SupplementII-31-b169","doi-asserted-by":"crossref","unstructured":"A. E. Yancey, D. J. Minion, and C. Rodriguez .et al.Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage., J Vasc Surg, 2006 .44 :503 \u2013509 .","DOI":"10.1016\/j.jvs.2006.05.038"},{"key":"i1545-1550-16-SupplementII-31-b170","doi-asserted-by":"crossref","unstructured":"D. E. Kandzari, R. S. Kiesz, and D. Allie .et al.Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia., J Endovasc Ther, 2006 .13 :12 \u201322 .","DOI":"10.1583\/05-1634.1"},{"key":"i1545-1550-16-SupplementII-31-b172","doi-asserted-by":"crossref","unstructured":"V. Ramaiah, R. Gammon, and S. Kiesz .et al.Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection., J Endovasc Ther, 2006 .13 :592 \u2013602 .","DOI":"10.1583\/05-1780MR.1"},{"key":"i1545-1550-16-SupplementII-31-b173","doi-asserted-by":"crossref","unstructured":"W. B. Keeling, M. L. Shames, and P. A. Stone .et al.Plaque excision with the SilverHawk catheter: early results in patients with claudication or critical limb ischemia., J Vasc Surg, 2007 .45 :25 \u201331 .","DOI":"10.1016\/j.jvs.2006.08.080"},{"key":"i1545-1550-16-SupplementII-31-b174","doi-asserted-by":"crossref","unstructured":"T. Zeller, A. Rastan, and U. Schwarzwalder .et al.Midterm results after atherectomy-assisted angioplasty of below-knee arteries with use of the Silverhawk device., J Vasc Interv Radiol, 2004 .15 :1391 \u20131397 .","DOI":"10.1097\/01.RVI.0000138060.05915.9D"},{"key":"i1545-1550-16-SupplementII-31-b175","unstructured":"M. Wholey, R. Suri, and D. Postoak .et al.Plaque excision in 2005 and beyond: issues of the past have yet to be resolved., Endovascular Today, 2005 .August :40 \u201344 ."},{"key":"i1545-1550-16-SupplementII-31-b176","doi-asserted-by":"crossref","unstructured":"R. Suri, M. H. Wholey, and D. Postoak .et al.Distal embolic protection during femoropopliteal atherectomy., Catheter Cardiovasc Interv, 2006 .67 :417 \u2013422 .","DOI":"10.1002\/ccd.20634"}],"container-title":["Journal of Endovascular Therapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:29:08Z","timestamp":1777498148000},"score":1,"resource":{"primary":{"URL":"http:\/\/jet.sagepub.com\/lookup\/doi\/10.1583\/08-2657.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":170,"journal-issue":{"issue":"SupplementII","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1583\/08-2657.1"],"URL":"https:\/\/doi.org\/10.1583\/08-2657.1","relation":{},"ISSN":["1526-6028","1545-1550"],"issn-type":[{"value":"1526-6028","type":"print"},{"value":"1545-1550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}